TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Change from pretest in child report of frequency of parent-child communication
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Change from pretest in parent report of frequency of parent-child communication
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Change from pretest in child report of general parent-child communication quality
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: change of energy expenditure (EE)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change from baseline in Postoperative Recovery Index (PoRI) at month 3
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline in Psychological Well-Being at month 3
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Variation of ADHD-RS (ADHD Rating Scale-IV)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Brief Psychiatric Rating Scale-24
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in Clinical Global Impression
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in Digital Symbol Substitution Test
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Change in World Health Organization Disability Assessment Schedule 2.0
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Number of Participants With Premature Treatment Discontinuation Due to AEs
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Participants With One or More Abnormal Laboratory Result
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in SF-36 questionnaire scores
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Functional recovery: status, plan and prognosis for employment versus sickness absence
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Functional recovery: sickness absence self-report
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Functional recovery: sickness absence registry data
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Functional recovery: disability benefits
Endpoint domain: Resource use
Endpoint subdomain: Societal/carer burden
Primary endpoint: expression of programmed death ligand-1 (PD-L1)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: mGOS (Modified Glasgow Outcome Score)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: numerical rating scale (NRS)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: NPSI-Eye (range 0-100 score)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Composite of time to first occurrence of stroke, cardiovascular death, or clinically relevant major or non-major bleeding events
Endpoint domain: Mortality/survival
Primary endpoint: Composite of time to first occurrence of ischemic stroke or systemic embolism
Endpoint domain: Mortality/survival
Primary endpoint: Change in total health care costs
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Difference between estimated intracranial pressure and actual intracranial pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Number of Participants That Completed Study
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Menstruation symptom
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: COVID-19 prevention knowledge
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: COVID-19 prevention intention and anxiety
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: COVID-19 prevention behavior
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Safety of inelastic compression
Endpoint domain: Adverse events/effects
Primary endpoint: Accuracy of pulse rate when wearer is at rest
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of deaths within 2 years of discharge from hospital
Endpoint domain: Mortality/survival
Primary endpoint: Proportion of re-hospitalization within 2 years of discharge from hospital
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: breast milk IgA levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Sperm DNA fragmentation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hypertensive Treatment Compliance
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Identification of Proteomic Biomarkers
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Identification of Metabolomic Biomarkers
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Delayed matching-to-place (DMP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cognitive functioning
Primary endpoint: The Montreal Cognitive Assessment - Hong Kong Version
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cognitive functioning
Primary endpoint: The Chinese Multiple Errands Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cognitive functioning
Primary endpoint: Change in pain intensity during intercourse
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Range of motion in flexion-extension
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Change of ADAS-Cog
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change of SARS-CoV-2 vaccination status
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change of Influenza vaccination status
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: sensitivity of PET/MR
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: specificity of PET/MR
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: accuracy of PET/MR
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Dynamic Acuity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Composite of death and stroke at 1 year
Endpoint domain: Mortality/survival
Primary endpoint: Recurrent Urinary Tract Infection Symptom Scale
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Recurrent Urinary Tract Infection Impact Questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Glasgow Edinburg Throat Scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Beck depression inventory
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: EOI MRD positivity >= 0.01%
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in upper and lower limb maximal strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in stenosis degree
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Annualized whole brain volume percentage change
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Oxygen Consumption Rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of participants with postoperative pancreatic fistula
Endpoint domain: Adverse events/effects
Primary endpoint: Change in hemodynamics of arterial blood supply to HCC tumors
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in the perfusion pattern of HCC tumors
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Frequency of tolerance to milk
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Successful use of arteriovenous fistula for dialysis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Presence of embryotoxicity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: degree of cardiac fibrosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Pain scores using Numeric Rating Scale (NRS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Pain, Enjoyment, and General Activity (PEG) Assessment Scores
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Patients and providers satisfaction
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Clinical management Complexity
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Cardiac function assessment via contrast-enhanced cardiac MRI
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Proportion of subjects with hemoglobin levels ≥ 12 g/dL
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Absolute perceived harm
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Relative perceived harm
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Absolute perceived addictiveness
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Relative perceived addictiveness
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Product appeal
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Use intention
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Spirometry availability
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from counseling duration
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change from Baseline of 12-Item Version of the Barrett-Lennard Relationship Inventory
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change from Baseline of the Measure of Empathy Scale
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Stroke-free survival to 30 days
Endpoint domain: Mortality/survival
Primary endpoint: Total amount of Gal-10 in saliva
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total amount of Gal-7 in saliva
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total amount of MMP-9 in saliva
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PFA ablation lesion chronicity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Target Lesion Failure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: FC
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Alb
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to glycemic goal
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Effect on E.F.
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Effect on liver function
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Change in serum Potassium
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in symptoms measured by personalized symptom score sheet
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Accuracy of automatic detection of periapical radiolucent lesions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: incidence of catheter related bladder discomfort
Endpoint domain: Adverse events/effects
Primary endpoint: Acceptability of CAB-LA PrEP
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Device Oriented Clinical Endpoint
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of successful diagnostic cerebral angiography
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: MR3.0 or less by 1 year
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Differential microRNA expression
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: POSAS score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Measurement of chemical composition in exhaled breath
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Assessment of COVID status using nasal swab
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sensitivity of ROMA
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Specificity of ROMA
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of participants achieving sustained viral response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes from baseline in serum HBsAg levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: small airways endpoints
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Change in glutathione concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in cholesterol concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change from Baseline (CFB) to Week 12 on mADL11
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of participants that maintain response following randomized withdrawal
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of participants with Adverse Events (AE) and their severity
Endpoint domain: Adverse events/effects
Primary endpoint: Change of seroprevalence of anti-SARS-CoV-2 antibodies
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Diagnosis of MAFLD
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Changes in hematocrit count
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Patient outcome
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Complications of medical interest
Endpoint domain: Adverse events/effects
Primary endpoint: Lack of compliance with cervical spine imaging order
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Strabismus
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Amblyopia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CT scan results for syndesmosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Gross motor function classification System (GMFCS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Arabic Version of Zarit burden Inventory measure
Endpoint domain: Life impact
Endpoint subdomain: Societal/carer burden
Primary endpoint: anti-SARS-CoV-2 neutralising antibody response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Average difference in HbA1c values
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in visceral adiposity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Rate of progression from prediabetes to diabetes
Endpoint domain: Mortality/survival
Primary endpoint: Incidence of acute phase response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Safety of BCG challenge
Endpoint domain: Adverse events/effects
Primary endpoint: Microbial community structure in patients with CO urolithiasis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Microbial community structure in patients with RCC
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Microbial community structure in healthy participants
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Linear Measurements
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Health-related quality of life as measured by the HRQOL-14
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Change in Blood Insulin Levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in Blood Lipid Levels as Assessed by Lipid Panel
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Peak Viral Load (PVL)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Area Under the Viral Load-time Curve (VL-AUC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Proportion of social network members who report cervical cancer screening
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Stroke Pattern Characteristic Descriptions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reliability of IASTM Force Application
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reliability of Dynamic Pressure Pain Threshold Assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Breath cannabinoid concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in the Toronto Extremity Salvage Score (TESS)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Muscle strength-handgrip
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Muscle performance-gait speed
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Dimension of the Anterior Midpalatal Suture Opening
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in NRS scores for pain intensity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Visual Analog Scale
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: HIV Stigma
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: CMAP distal latency
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: CMAP amplitude
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: CMAP duration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Post-operative Atrial fibrillation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Immunogenicity of MVC-COV1901
Endpoint domain: Physiological/clinical
Primary endpoint: Change in percent transthyretin stability assay
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of participants with MRI characteristics of breast lesions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Metabolomic Profile
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Uptake Rate of Vaccines
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: cumulative opioid dose
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Frontal lobe and corpus callosum volumes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Difference in bacterial DNA sequencing
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in clonal diversity of B-Cell response to Influenza in blood
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Changes in clonal diversity of B-Cell response to Influenza in bone marrow
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Changes in magnitude of B-Cell response to Influenza in blood
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Changes in magnitude of B-Cell response to Influenza in bone marrow
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Changes in persistence of B-Cell response to Influenza in blood
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Stability of interventional cardiology procedures results
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Evaluation of the study biomarkers, IL-6, and VEGF
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Synthetic score on standardized assessment scale of anxiety
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Maximum Serum Concentration of Agalsidase Beta (Cmax)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area Under the Curve of Serum Concentration Between Times 0 and 12 Hours of Agalsidase Beta
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time at Which Maximum Serum Concentration of Agalsidase Beta is Observed (Tmax)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes